Atezolizumab in Combination With Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery for Patients With Newly-Diagnosed Advanced-Stage Epithelial Ovarian Cancer
Phase of Trial: Phase I/II
Latest Information Update: 21 Aug 2019
Price : $35 *
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab; Carboplatin; Paclitaxel
- Indications Carcinoma; Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- Acronyms AdORN
- 31 Aug 2018 Biomarkers information updated
- 31 Jul 2018 Status changed from not yet recruiting to recruiting.
- 08 Jun 2018 Planned initiation date changed from 1 May 2018 to 1 Jun 2018.